Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Allos Therapeutics, Inc. - Allos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the European Commission
Kamada - Kamada Completes Last Patient Visit in Phase II Bronchiectasis Study with its Inhaled AAT
B-Cell Lymphoma - Studies from University of Manchester describe new findings in B-cell lymphoma
Breast Cancer - New breast cancer data have been reported by B. Mlineritsch and co-authors
Dialysis - Findings from R. Provenzano and co-authors provide new insights into dialysis
Dialysis - Research from C.W. Mcintyre and co-authors reveals new findings on dialysis
Heart Disease - Studies conducted at University of Michigan on heart disease recently published
Life Sciences - New findings from A.D. Barreto and co-authors in the area of life sciences published
Non-Small Cell Lung Cancer - Studies from S.K. Seung and co-researchers update current data on non-small cell lung cancer
Prostate Cancer - Reports outline prostate cancer research from University of California
Prostate Cancer - Studies from University of Gottingen yield new data on prostate cancer
Prostate Cancer - Study results from M.J. Morris and colleagues update understanding of prostate cancer
Renal Cell Carcinoma - New findings in renal cell carcinoma described from Medical College of Wisconsin, Medical College
Renal Cell Carcinoma - Research on renal cell carcinoma discussed by R.J. Motzer and co-researchers
Vaccines - Research from Brigham and Women's Hospital provides new data on vaccines
Clinical Trial Research - Studies from University of Warwick, Department of Statistics in the area of clinical trial research published
Mantle Cell Lymphoma Therapy - Reports from Columbia University, Herbert Irving Comprehensive Cancer Center add new data to research in mantle cell lymphoma therapy
Bioengineering - Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
Biokine Therapeutics, Ltd. - Biokine Announces $1.2 Million Research Grant by the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel
Biopharmaceuticals - Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
Cancer - Another LNA-based RNA Inhibitor Enters Clinical Trials
Celiac Disease - Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
Clinical Trial Research - BioMarin's Clinical Trial Application for GALNS for Morquio a Syndrome Accepted by the MHRA
Concert Pharmaceuticals, Inc. - Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347
CyDex Pharmaceuticals, Inc. - CyDex Pharmaceuticals Presents Phase 2 Clinical Trial Results for Captisol-Enabled® Budesonide/Azelastine Combination Solution Nasal Spray at American Academy of Allergy Asthma and Immunology AAAAI Meeting
Cytochroma - Cytochroma announces new findings regarding the role of CYP24 in chronic kidney disease
Drug Development - Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
Durect Corporation - DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
Emergent BioSolutions Inc. - Emergent BioSolutions Announces Commencement of Phase I/II Clinical Trial of Anthrax Immune Globulin for Treating Anthrax Disease
Flu Vaccines - Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
JAMA and Archives Journals - New type of botulinum toxin appears to be well tolerated and may help reduce forehead wrinkles
Merck & Co., Inc. - Merck & Co., Inc. Donates Antimalarial Candidate to Medicines for Malaria Venture for Use in Developing World
Prostate Cancer - Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
